CATAPLEXY
Clinical trials for CATAPLEXY explained in plain language.
Never miss a new study
Get alerted when new CATAPLEXY trials appear
Sign up with your email to follow new studies for CATAPLEXY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for long-term control of sudden muscle weakness and sleepiness in narcolepsy
Disease control CompletedThis study tested whether the drug AXS-12 could safely control two main narcolepsy symptoms—cataplexy (sudden muscle weakness) and excessive daytime sleepiness—over a longer period. It involved 68 people with narcolepsy who had already taken part in a previous trial. For 24 weeks…
Matched conditions: CATAPLEXY
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New One-Dose-Nightly pill tested for narcolepsy safety
Disease control CompletedThis study tested the long-term safety and tolerability of a new, once-nightly version of a narcolepsy medication called FT218. It involved 184 people with narcolepsy, including those already taking a similar twice-nightly drug and those new to this type of treatment. The main go…
Matched conditions: CATAPLEXY
Phase: PHASE3 • Sponsor: Avadel • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC